CorMedix (CRMD) CFO Susan Blum reports no beneficial ownership on Form 3

Rhea-AI Filing Summary

CorMedix Inc. Chief Financial Officer Susan Blum filed an initial ownership report on Form 3 in connection with her role as an officer of CorMedix Inc. The filing states that no securities of CorMedix Inc. are beneficially owned, and both the non-derivative and derivative ownership tables show no holdings. The form is filed by a single reporting person in her capacity as Chief Financial Officer.

SEC Form 3

FORM 3

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0104
Estimated average burden
hours per response:			0.5

1. Name and Address of Reporting Person^*

Blum Susan

(Last) (First) (Middle)

C/O CORMEDIX INC.

300 CONNELL DRIVE, SUITE 4200

(Street)

BERKELEY HEIGHTS NJ 07922

(City) (State) (Zip)

2. Date of Event Requiring Statement (Month/Day/Year)
08/29/2025

3. Issuer Name and Ticker or Trading Symbol
CorMedix Inc. [ CRMD ]

4. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	Chief Financial Officer

5. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Beneficially Owned
1. Title of Security (Instr. 4)	2. Amount of Securities Beneficially Owned (Instr. 4)	3. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	4. Nature of Indirect Beneficial Ownership (Instr. 5)

Table II - Derivative Securities Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 4)	2. Date Exercisable and Expiration Date (Month/Day/Year)		3. Title and Amount of Securities Underlying Derivative Security (Instr. 4)		4. Conversion or Exercise Price of Derivative Security	5. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	6. Nature of Indirect Beneficial Ownership (Instr. 5)
	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

No securities are beneficially owned.

	/s/ Susan Blum	09/03/2025
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 5 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What does the CorMedix (CRMD) Form 3 filed by CFO Susan Blum report?

The Form 3 filed by Susan Blum, Chief Financial Officer of CorMedix Inc., reports her initial beneficial ownership position in the company’s securities in connection with her role as an officer.

How many CorMedix (CRMD) shares does CFO Susan Blum beneficially own according to this Form 3?

The filing states in the explanation of responses that no securities are beneficially owned by the reporting person.

Are there any derivative securities reported by CorMedix (CRMD) CFO Susan Blum on this Form 3?

No. The table for derivative securities beneficially owned contains no entries, and the explanation confirms that no securities are beneficially owned.

What is Susan Blum’s relationship to CorMedix (CRMD) as disclosed in the Form 3?

The Form 3 identifies Susan Blum as an officer of CorMedix Inc., serving as the company’s Chief Financial Officer.

Is the CorMedix (CRMD) Form 3 filed by one or multiple reporting persons?

The document indicates that the Form 3 is filed by one reporting person, namely Chief Financial Officer Susan Blum.

Does the CorMedix (CRMD) Form 3 indicate any transactions by Susan Blum?

No transactions are listed. The filing contains no entries in the transaction tables and notes that no securities are beneficially owned.